Fluorescent sensor demonstrates biocompatibility and low cytotoxicity, indicating potential for Zr4+, H2PO4–, and vitamin B1 detection in living cells.
A new N/O polydentate ligand with benzothiadiazole units (4-(7-(1H-pyrazol-4-yl)benzo[c][1,2,5]thiadiazol-4-yl)benzoic acid, H₂PZBTB) has been used to synthesize a stable zinc(II) metal-organic framework (MOF) under solvothermal conditions with the formula {[Zn₂(PZBTB)₂(H₂O)₂]·0.5DMF}n (JXUST-60, where JXUST denotes Jiangxi University of Science and Technology; DMF = dimethylformamide). JXUST-60 possesses a two-dimensional (2D) planar architecture, while interlayer interactions via π-π stacking result in the formation of a three-dimensional (3D) packing structure. JXUST-60 maintains structural integrity after being immersed in water and aqueous solutions with pH = 3-13 for 24 h. Fluorescence sensing experiments demonstrate that JXUST-60 can function as a turn-on MOF sensor for Zr⁴⁺, dihydrogen phosphate (H₂PO₄⁻), and vitamin B1 (VB1) through naked-eye recognition, with low detection limits of 0.06, 0.13, and 0.09 μM, respectively. It is worth noting that JXUST-60 is a rare sensor that recognizes VB1 through the turn-on effect and is the only ZnII MOF fluorescence sensor capable of recognizing Zr⁴⁺ to date. In addition, the cyclic test demonstrates that JXUST-60 is a reusable sensor material. More importantly, JXUST-60 has good biocompatibility and low cytotoxicity to sense VB1 in living cells.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: